Clinical Trials Logo

Clinical Trial Summary

To evaluate the safety and efficacy of an investigational version of the Cutera enLighten laser that offers muliple wavelengths for tattoo removal.


Clinical Trial Description

Currently, the enLighten laser offers two wavelengths: 532nm and 1064nm. The version of the laser under investigation allows the user to choose a wavelength between 640nm to 800nm. This is a multi-center prospective, open-label, uncontrolled pilot study in up to 75 male or female subjects, age 18 to 65 years, who desire laser removal of a tattoo containing single or multi-color ink. Subjects will receive laser treatments and will be followed at 6 weeks. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03290547
Study type Interventional
Source Cutera Inc.
Contact
Status Completed
Phase N/A
Start date July 8, 2015
Completion date November 29, 2017

See also
  Status Clinical Trial Phase
Completed NCT02912507 - Split-tattoo Study Comparing the Safety and Efficacy of 670nm Picosecond Laser Versus 755 nm for Tattoo Removal N/A
Completed NCT01973166 - Study of Picosecond and Nanosecond Q-switched Lasers for Tattoo Removal N/A
Recruiting NCT06202274 - Clinical Study to Evaluate the Safety and Efficacy of Candela Technology N/A
Completed NCT05102617 - Post Market Usability Evaluation Of The PicoSure Pro Device N/A
Completed NCT02910505 - A Study of a Novel Multi-Wavelength Laser for Tattoo Removal N/A
Completed NCT02935660 - Multi-Wavelength Laser Tattoo Removal Pivotal Study N/A
Completed NCT02244554 - Comparison Study of Picosecond and Nanosecond Pulse Durations Using a Q-switched Nd:YAG Laser for Tattoo Removal N/A
Completed NCT01624688 - Optimizing Tattoo Removal: a Side-by-side Comparison in the Search for One Treatment Tattoo Removal N/A
Recruiting NCT03866304 - Performance Evaluation of Tattoo Removal N/A
Terminated NCT02756806 - A Clinical Evaluation for Tattoo Removal N/A